marketcaparena
Search

    PLYX

    Polaryx Therapeutics, Inc.

    Company overview

    Market capitalization
    $101.69M
    Employees
    2
    Latest publication
    2026-09-29
    About Polaryx Therapeutics, Inc.

    Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue0USD0USD0USD0USD0USD0USD0USD
    Research Development679,000USD560,000USD514,000USD476,000USD4,716,000USD350,000USD354,000USD
    Selling General Administrative1,279,000USD351,000USD460,000USD408,000USD336,000USD373,000USD417,000USD
    Total Operating Expenses1,958,000USD911,000USD974,000USD884,000USD5,052,000USD723,000USD771,000USD
    Operating Income-1,958,000USD-911,000USD-974,000USD-884,000USD-5,052,000USD-723,000USD-771,000USD
    Income Before Tax-2,544,000USD-1,495,000USD-1,430,000USD-1,008,000USD-5,052,000USD-723,000USD-771,000USD
    Net Income-2,544,000USD-1,495,000USD-1,430,000USD-1,008,000USD-5,052,000USD-723,000USD-771,000USD
    Net Income From Continuing Ops-2,544,000USD-1,495,000USD-1,430,000USD-1,008,000USD-5,052,000USD-723,000USD-771,000USD
    Ebitda-1,958,000USD-911,000USD-974,000USD-884,000USD-5,052,000USD-723,000USD-771,000USD
    Total Other Income Expense Net-586,000USD-584,000USD-456,000USD-124,000USD—0USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Total Revenue0USD0USD0USD
    Research Development6,266,000USD2,811,000USD2,771,000USD
    Selling General Administrative1,555,000USD1,541,000USD1,010,000USD
    Total Operating Expenses7,821,000USD4,352,000USD3,781,000USD
    Operating Income-7,821,000USD-4,352,000USD-3,781,000USD
    Income Before Tax-8,985,000USD-30,356,000USD-3,779,000USD
    Net Income-8,985,000USD-30,356,000USD-3,779,000USD
    Net Income From Continuing Ops-8,985,000USD-30,356,000USD-3,779,000USD
    Ebitda-7,821,000USD-4,352,000USD-3,781,000USD
    Total Other Income Expense Net-1,164,000USD-26,004,000USD2,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets11,812,000USD3,502,000USD5,420,000USD5,983,000USD3,543,000USD4,438,000USD5,001,000USD—
    Cash And Equivalents11,542,000USD———————
    Total Current Assets11,812,000USD3,502,000USD5,170,000USD5,983,000USD3,543,000USD4,438,000USD5,001,000USD—
    Total Liabilities873,000USD———————
    Total Current Liabilities873,000USD1,014,000USD605,000USD682,000USD296,000USD185,000USD289,000USD—
    Other Current Liabilities73,000USD———————
    Total Stockholder Equity10,939,000USD2,488,000USD4,565,000USD5,301,000USD3,247,000USD4,253,000USD4,712,000USD—
    Total Equity Including Noncontrolling Interest10,939,000USD———————
    Accounts Payable683,000USD850,000USD470,000USD496,000USD158,000USD55,000USD72,000USD—
    Common Stock5,000USD5,000USD5,000USD19,000USD18,000USD18,000USD16,000USD—
    Retained Earnings-103,559,000USD-102,179,000USD-99,635,000USD-98,140,000USD-96,710,000USD-95,704,000USD-90,650,000USD—
    Other Current Assets—422,000USD27,000USD238,000USD239,000USD276,000USD380,000USD—
    Total Liab—1,014,000USD855,000USD682,000USD296,000USD185,000USD289,000USD—
    Other Current Liab—164,000USD135,000USD186,000USD138,000USD130,000USD217,000USD—
    Capital Stock—5,000USD5,000USD19,000USD18,000USD18,000USD16,000USD—
    Cash—3,080,000USD5,143,000USD5,745,000USD3,304,000USD4,162,000USD4,621,000USD—
    Cash And Short Term Investments—3,080,000USD5,143,000USD5,745,000USD3,304,000USD4,162,000USD4,621,000USD—
    Net Debt—-3,080,000USD-5,143,000USD-5,745,000USD-3,304,000USD-4,162,000USD-4,621,000USD—
    Common Stock Shares Outstanding—47,219,329shares47,343,297shares189,372,654shares189,372,654shares189,372,654shares189,372,654shares189,372,654shares
    Non Current Assets Total—0USD250,000USD0USD0USD0USD0USD—
    Non Current Liabilities Total—0USD250,000USD0USD0USD0USD0USD—
    Net Working Capital—2,488,000USD4,565,000USD5,301,000USD3,247,000USD4,253,000USD4,712,000USD—
    Unclassified Equity—104,657,000USD104,190,000USD103,403,000USD99,921,000USD99,921,000USD95,330,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Total Assets5,420,000USD5,001,000USD2,315,000USD
    Other Current Assets27,000USD380,000USD2,313,000USD
    Total Liab855,000USD289,000USD1,038,000USD
    Total Stockholder Equity4,565,000USD4,712,000USD1,277,000USD
    Other Current Liab135,000USD217,000USD437,000USD
    Common Stock5,000USD16,000USD4,000USD
    Capital Stock5,000USD16,000USD4,000USD
    Retained Earnings-99,635,000USD-90,650,000USD-60,294,000USD
    Cash5,143,000USD4,621,000USD2,000USD
    Cash And Short Term Investments5,143,000USD4,621,000USD2,000USD
    Total Current Assets5,170,000USD5,001,000USD2,315,000USD
    Total Current Liabilities605,000USD289,000USD1,038,000USD
    Net Debt-5,143,000USD-4,621,000USD126,000USD
    Accounts Payable470,000USD72,000USD473,000USD
    Common Stock Shares Outstanding47,343,297shares189,372,654shares189,372,654shares
    Non Current Assets Total250,000USD0USD0USD
    Non Current Liabilities Total250,000USD0USD0USD
    Net Working Capital4,565,000USD4,712,000USD1,277,000USD
    Unclassified Equity104,190,000USD95,330,000USD61,563,000USD
    Short Term Debt——128,000USD
    Short Long Term Debt——128,000USD
    Short Long Term Debt Total——128,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation467,000USD
    Change To Liabilities213,000USD
    Change In Working Capital-30,000USD
    Operating Cash Flow-3,432,000USD
    Financing Cash Flow9,831,000USD
    Change In Cash6,399,000USD
    End Cash Flow11,542,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Net Income-2,544,000USD-1,495,000USD-1,430,000USD-1,008,000USD-5,052,000USD-723,000USD-771,000USD
    Stock Based Compensation467,000USD57,000USD108,000USD109,000USD4,451,000USD87,000USD0USD
    Change In Working Capital14,000USD-52,000USD435,000USD41,000USD-108,000USD-224,000USD-561,000USD
    Total Cash From Operating Activities-2,063,000USD-1,490,000USD-887,000USD-858,000USD-709,000USD-860,000USD-1,332,000USD
    Capital Expenditures0USD0USD0USD0USD0USD0USD0USD
    Free Cash Flow-2,063,000USD-1,490,000USD-887,000USD-858,000USD-709,000USD-860,000USD-1,332,000USD
    Total Cash From Financing Activities0USD888,000USD3,328,000USD0USD250,000USD2,750,000USD0USD
    Issuance Of Capital Stock0USD759,000USD3,484,000USD0USD250,000USD2,750,000USD0USD
    Change In Cash-2,063,000USD-602,000USD2,441,000USD-858,000USD-459,000USD1,890,000USD-1,332,000USD
    Begin Period Cash Flow5,143,000USD5,745,000USD3,304,000USD4,162,000USD4,621,000USD2,731,000USD4,063,000USD
    End Period Cash Flow3,080,000USD5,143,000USD5,745,000USD3,304,000USD4,162,000USD4,621,000USD2,731,000USD
    Other Non Cash Items—57,000USD———0USD0USD
    Net Borrowings—0USD0USD0USD0USD0USD0USD
    Other Cashflows From Financing Activities——-156,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Net Income-8,985,000USD-30,356,000USD-3,779,000USD
    Stock Based Compensation4,725,000USD2,400,000USD3,237,000USD
    Other Non Cash Items4,725,000USD26,004,000USD—
    Change In Working Capital316,000USD-621,000USD369,000USD
    Total Cash From Operating Activities-3,944,000USD-2,573,000USD-173,000USD
    Capital Expenditures0USD0USD0USD
    Free Cash Flow-3,944,000USD-2,573,000USD-173,000USD
    Net Borrowings0USD-128,000USD128,000USD
    Total Cash From Financing Activities4,466,000USD7,192,000USD128,000USD
    Issuance Of Capital Stock4,493,000USD7,320,000USD0USD
    Change In Cash522,000USD4,619,000USD-45,000USD
    Begin Period Cash Flow4,621,000USD2,000USD47,000USD
    End Period Cash Flow5,143,000USD4,621,000USD2,000USD
    Unclassified Operating Cash Flow-4,725,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.